BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2026
Becton Dickinson & Co BDX
News
BD and Global Health Leaders Call for Accelerated Maternal Life Saving Measures Worldwide
BD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial Results
BD Celebrates 65 Years of Manufacturing, Innovation and Community Partnership in Canaan
Becton Dickinson to Invest $19 Billion in U.S. in Exchange for Tariff Relief — Update
Becton Dickinson Inks Deal With Trump Administration to Invest $19 Billion in U.S. in Exchange for Tariff Relief
BD Appoints Ferass Abuzaina as Worldwide President of Surgery
BD and U.S. Government Launch Landmark Partnership to Expand U.S. Manufacturing and Strengthen America's Healthcare Resilience
BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy
Arthur Hu to Join BD as Chief Information and Digital Officer
BD Advances Intelligent Robotics to Transform the Future of Pharmacy Care at Fairview
BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation
BD to Present at Wells Fargo 21st Annual Healthcare Conference
BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire
BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial
BD Reports Third Quarter Fiscal 2026 Financial Results
EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch
BD Board Declares Dividend
Mike Garrison to Retire from BD
Becton Dickinson Resumes U.S. Shipments of ChloraPrep
United States